colestipol has been researched along with Xanthoma in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (75.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (12.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hegele, RA; Lewis, GF; Xiao, C | 1 |
| Debry, G; Demange, J; Drouin, P; Lambert, L; Sauvanet, JP | 1 |
| Desager, JP; Harvengt, C | 1 |
| Hayase, K; Kostis, JB; Kuo, PT; Moreyra, AE | 1 |
| Baggio, G; Baiocchi, MR; Balestrieri, P; Briani, G; Crepaldi, G; Fellin, R | 1 |
| Baker, AL; Chow, MJ; Hay, RV; Rosenson, RS | 1 |
| Beltz, WF; Juliano, J; Kelly, N; Lester, P; Simmons, D; Steinberg, D; Weinreb, R; Witztum, JL; Young, SG | 1 |
| Parker, F | 1 |
3 trial(s) available for colestipol and Xanthoma
| Article | Year |
|---|---|
Colestipol in familial type II hyperlipoproteinemia: a three-year trial.
Topics: Adolescent; Adult; Child; Cholesterol; Clinical Trials as Topic; Colestipol; Female; Humans; Hypercholesterolemia; Hyperlipidemias; Lipoproteins, LDL; Lipoproteins, VLDL; Male; Middle Aged; Placebos; Polyamines; Triglycerides; Xanthomatosis | 1976 |
Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
Topics: Adult; Aged; Angina Pectoris; Arteriosclerosis; Cholesterol; Colestipol; Coronary Disease; Dietary Carbohydrates; Dietary Fats; Drug Evaluation; Female; Follow-Up Studies; Humans; Hyperlipidemias; Lipoproteins, HDL; Lipoproteins, LDL; Male; Middle Aged; Myocardial Infarction; Patient Compliance; Placebos; Polyamines; Radiography; Triglycerides; Xanthomatosis | 1979 |
Intensive combination drug therapy of familial hypercholesterolemia with lovastatin, probucol, and colestipol hydrochloride.
Topics: Cholesterol; Clinical Trials as Topic; Colestipol; Drug Interactions; Drug Therapy, Combination; Humans; Hyperlipoproteinemia Type II; Lipoproteins, HDL; Lipoproteins, LDL; Lovastatin; Phenols; Polyamines; Probucol; Prospective Studies; Triglycerides; Xanthomatosis | 1989 |
5 other study(ies) available for colestipol and Xanthoma
| Article | Year |
|---|---|
Treatment of Severe Hypercholesterolemia in a Woman With Advanced Primary Sclerosing Cholangitis.
Topics: Adult; Cholagogues and Choleretics; Cholangitis, Sclerosing; Colestipol; Facial Dermatoses; Female; Hand Dermatoses; Humans; Hypercholesterolemia; Hypolipidemic Agents; Lipoprotein-X; Plasma Exchange; Severity of Illness Index; Skin Diseases; Ursodeoxycholic Acid; Xanthomatosis | 2017 |
[Familial hypercholesterolemic xanthomatosis: effect of colestipol on the lipoprotein profile].
Topics: Colestipol; Hyperlipoproteinemia Type II; Polyamines; Xanthomatosis | 1980 |
[Long term treatment of familial hypercholesterolemia with Colestipol, a new anionic exchange resin (author's transl)].
Topics: Adult; Angina Pectoris; Cholesterol; Colestipol; Coronary Disease; Drug Evaluation; Female; Humans; Hyperlipidemias; Male; Middle Aged; Myocardial Infarction; Polyamines; Triglycerides; Xanthomatosis | 1975 |
Hyperviscosity syndrome in a hypercholesterolemic patient with primary biliary cirrhosis.
Topics: Blood Viscosity; Cholesterol; Cholesterol, Dietary; Colestipol; Combined Modality Therapy; Female; Humans; Hypercholesterolemia; Liver Cirrhosis, Biliary; Middle Aged; Plasma Exchange; Recurrence; Syndrome; Xanthomatosis | 1990 |
Xanthomas and hyperlipidemias.
Topics: Apoproteins; Arteriosclerosis; Cholestasis; Cholestyramine Resin; Clofibrate; Colestipol; Dextrothyroxine; Diabetes Complications; Female; Humans; Hyperlipidemias; Hyperlipoproteinemia Type III; Hyperlipoproteinemia Type IV; Hyperlipoproteinemias; Hypolipidemic Agents; Hypothyroidism; Kidney Diseases; Lipoproteins; Male; Neomycin; Niacin; Obesity; Pancreatitis; Xanthomatosis | 1985 |